Lumexa Imaging Holdings Inc. (LMRI)
NASDAQ: LMRIHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LMRI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.37B
- Forward P/E
- 15.18
- EPS (TTM)
- -$0.26
- Dividend yield
- None
- 52-week range
- 6.45 – 19.45
- Day range
- 13.87 – 14.47
- Volume / Avg
- 442.42K / 372.45K
- Beta
- —
- Shares outstanding
- 96.12M
52-week range
LMRI stock today
Shares of Lumexa Imaging (LMRI) finished higher on Nov 20 at $14.26, a gain of 1.42% or $0.20 per share, versus the S&P 500's 3.70% decline. At this level, LMRI sits in the middle of its 52-week range of $6.45 to $19.45: 26.7% below the high, set on Dec 15, 2025 and 121.1% above the low. LMRI is down 22.9% year to date, underperforming the S&P 500 (+1.2%).
Lumexa Imaging has posted a net loss over the last twelve months (EPS of -$0.26), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Lumexa Imaging
Company profileLumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Ms. Caitlin Zulla
- Headquarters
- Raleigh, NC
- Employees
- 5,000
- IPO year
- 2025
- Website
- lumexaimaging.com
Analyst forecast
ForecastConsensus (10 analysts)
strong_buy
Avg. price target
$18.78+31.70%
- Strong buy 2
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $0.14 vs $0.07
- Surprise
- +100.00%
LMRI news
All LMRI news- Lumexa Imaging Opens Three New Imaging Centers in NovemberGlobeNewswire
- Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint VentureGlobeNewswire
- Lumexa Turns Profit In Q3 At $7 Mln With Increased Outpatient Volume; To Open Three New CentersNasdaqLMRI, ET
- Lumexa Imaging Holdings, Inc. Non-GAAP EPS of $0.26 beats by $0.08, revenue of $272M beats by $2.11MSeeking Alpha
- Lumexa Imaging Announces Third Quarter 2026 ResultsGlobeNewswire
- Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call DateGlobeNewswire
Lumexa Imaging peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ALHCAlignment Healthcare Inc. | 6.37 | -2.00% | $1.33B | vs LMRI |
| TRUPTrupanion Inc. | 35.56 | -0.86% | $1.54B | vs LMRI |
| PSNLPersonalis Inc. | 14.27 | -3.06% | $1.55B | vs LMRI |
| FRNMFreenome Inc. | 9.36 | -5.69% | $1.04B | vs LMRI |
| CSTLCastle Biosciences Inc. | 32.86 | -1.63% | $1.01B | vs LMRI |
| FTREFortrea Holdings Inc. | 18.55 | -7.94% | $1.79B | vs LMRI |
| CLOVClover Health Investments Corp. Class A | 3.73 | -1.06% | $2.00B | vs LMRI |
| VCYTVeracyte Inc. | 25.13 | +0.36% | $2.03B | vs LMRI |
Indexes, lists and sector
Lumexa Imaging stock FAQ
What is Lumexa Imaging's stock price today?
LMRI last traded at $14.26 as of Nov 20, 4:00 PM EST, up 1.42% on the day. Prices are delayed at least 15 minutes.
Who is Lumexa Imaging's CEO?
Ms. Caitlin Zulla is the chief executive officer of Lumexa Imaging Holdings Inc., which has about 5,000 employees.
What is the LMRI 52-week high?
The 52-week high for LMRI is $19.45 and the 52-week low is $6.45. The stock is currently 26.7% below its high.